Here are four things to know.
1. CHS shares tumbled midday March 13 after the Reorg Research report was released.
2. CHS shares ended the day down 9.8 percent at $4.49 per share.
3. According to the Reorg Research report, attorneys from Davis Polk had a call with more than a dozen of CHS’ loan lenders March 9 to discuss potential restructuring options the company could pursue.
4. Sources told Reorg Research the lenders do not plan to challenge CHS’ latest amendment to its debt.
Access the full Reorg Research report here.
More articles on healthcare finance:
Wisconsin hospital at risk of losing Medicare contract over injuries to babies
Wyoming hospital resolves 20 malpractice suits that pushed it into bankruptcy
Miami hospital files for bankruptcy: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.